Pronova Defeats Teva, Par In Lovaza Patent Suit
A Delaware federal judge ruled Tuesday that Teva Pharmaceuticals USA Inc. and Par Pharmaceutical Inc. infringed two Pronova Biopharma Norge AS patents when they filed applications to sell a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article